Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

NCT06467383 is registered in ClinicalTrials.gov with MSD Italia S.r.l. as lead sponsor.

NCT NCT06467383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06467383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Lead sponsor
MSD Italia S.r.l.
Phase
Observational
Overall status
Recruiting
Start date
June 25, 2024
Completion date
June 24, 2025
Enrollment
600 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, nsclc, nsclc, stage i, nsclc, stage iii